Trials / Completed
CompletedNCT03751683
Evaluation Genotypic, Phenotypic and Prognosis APECED Syndrome
Evaluation Genotypic, Phenotypic and Prognosis Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 29 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of the study will define the mutational spectrum in this French cohort, in patients with APECED syndrome genetically authenticated
Conditions
Timeline
- Start date
- 2009-07-30
- Primary completion
- 2018-01-25
- Completion
- 2018-01-25
- First posted
- 2018-11-23
- Last updated
- 2025-12-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03751683. Inclusion in this directory is not an endorsement.